International Endeavors Corp (IDVV)

[Spread Medic]

Temecula, CA -- November 16, 2017 -- InvestorsHub NewsWire -- International Endeavors Corporation (IDVV) ("IEC") today announced it has received Pink Current Status from OTC Markets as part of the company's corporate restructure with KUBBY Cryogenics, Inc., subsidiary partner of IEC, and biomedical cannabis research and development firm.

Nate Engel, CEO, stated: "Now that the company is current with OTC Markets, we look forward to greater market liquidity while pursuing the Company's business restructuring objectives. The Company has already been working with KUBBY Cryogenics to secure several strains of Medical Marijuana to be patented and used in it's proprietary extraction method that captures the live resins that have medical benefits for a number of ailments, including: cancer, inflammatory disease, epilepsy, brain injury, autism, Alzheimer's, to name a few. The Company plans to announce the additions to the Board including Steve Kubby as well as several scientific advisors shortly."